P14672 (GTR4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 157.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Solute carrier family 2, facilitated glucose transporter member 4 Alternative name(s): Glucose transporter type 4, insulin-responsive Short name=GLUT-4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 509 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Insulin-regulated facilitative glucose transporter. |
| Subunit structure | Interacts with NDUFA9 By similarity. Binds to DAXX. Interacts via its N-terminus with SRFBP1. Ref.6 Ref.7 |
| Subcellular location | Cell membrane; Multi-pass membrane protein By similarity. Endomembrane system; Multi-pass membrane protein. Cytoplasm › perinuclear region. Note: Localizes primarily to the perinuclear region, undergoing continued recycling to the plasma membrane where it is rapidly reinternalized. The dileucine internalization motif is critical for intracellular sequestration. Ref.5 |
| Tissue specificity | Skeletal and cardiac muscles; brown and white fat. |
| Post-translational modification | Sumoylated. Ref.6 |
| Involvement in disease | Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. |
| Miscellaneous | Insulin-stimulated phosphorylation of TBC1D4 is required for GLUT4 translocation By similarity. |
| Sequence similarities | Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily. [View classification] |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| DAXX | Q9UER7 | 7 | EBI-367146,EBI-77321 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 509 | 509 | Solute carrier family 2, facilitated glucose transporter member 4 | PRO_0000050363 | |||||
Regions | |||||||||
| Topological domain | 1 – 24 | 24 | Cytoplasmic Potential | ||||||
| Transmembrane | 25 – 45 | 21 | Helical; Name=1; Potential | ||||||
| Topological domain | 46 – 81 | 36 | Extracellular Potential | ||||||
| Transmembrane | 82 – 102 | 21 | Helical; Name=2; Potential | ||||||
| Topological domain | 103 – 111 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 112 – 132 | 21 | Helical; Name=3; Potential | ||||||
| Topological domain | 133 – 142 | 10 | Extracellular Potential | ||||||
| Transmembrane | 143 – 163 | 21 | Helical; Name=4; Potential | ||||||
| Topological domain | 164 – 171 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 172 – 192 | 21 | Helical; Name=5; Potential | ||||||
| Topological domain | 193 – 201 | 9 | Extracellular Potential | ||||||
| Transmembrane | 202 – 222 | 21 | Helical; Name=6; Potential | ||||||
| Topological domain | 223 – 287 | 65 | Cytoplasmic Potential | ||||||
| Transmembrane | 288 – 308 | 21 | Helical; Name=7; Potential | ||||||
| Topological domain | 309 – 323 | 15 | Extracellular Potential | ||||||
| Transmembrane | 324 – 344 | 21 | Helical; Name=8; Potential | ||||||
| Topological domain | 345 – 353 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 354 – 374 | 21 | Helical; Name=9; Potential | ||||||
| Topological domain | 375 – 384 | 10 | Extracellular Potential | ||||||
| Transmembrane | 385 – 405 | 21 | Helical; Name=10; Potential | ||||||
| Topological domain | 406 – 417 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 418 – 438 | 21 | Helical; Name=11; Potential | ||||||
| Topological domain | 439 – 445 | 7 | Extracellular Potential | ||||||
| Transmembrane | 446 – 466 | 21 | Helical; Name=12; Potential | ||||||
| Topological domain | 467 – 509 | 43 | Cytoplasmic Potential | ||||||
| Region | 7 – 13 | 7 | SRFBP1-binding | ||||||
| Region | 295 – 297 | 3 | Defines substrate specificity By similarity | ||||||
| Motif | 489 – 490 | 2 | Dileucine internalization motif | ||||||
Amino acid modifications | |||||||||
| Modified residue | 274 | 1 | Phosphoserine; by SGK1 Ref.8 | ||||||
| Modified residue | 488 | 1 | Phosphoserine By similarity | ||||||
| Glycosylation | 57 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||
Natural variations | |||||||||
| Natural variant | 55 | 1 | S → R. Corresponds to variant rs35198331 [ dbSNP | Ensembl ]. | VAR_052503 | |||||
| Natural variant | 78 | 1 | T → S. Corresponds to variant rs5434 [ dbSNP | Ensembl ]. | VAR_012060 | |||||
| Natural variant | 358 | 1 | A → V. Corresponds to variant rs8192702 [ dbSNP | Ensembl ]. | VAR_020336 | |||||
| Natural variant | 383 | 1 | V → I in NIDDM. Ref.11 Ref.12 Ref.13 | VAR_007170 | |||||
| Natural variant | 385 | 1 | I → T. Ref.2 | VAR_007171 | |||||
Experimental info | |||||||||
| Mutagenesis | 489 – 490 | 2 | LL → AA: Changes subcellular location mainly to the plasma membrane. Ref.5 | ||||||
| Sequence conflict | 151 – 154 | 4 | Missing in AAA52569. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues." Fukumoto H., Kayano T., Buse J.B., Edwards Y., Pilch P.F., Bell G.I., Seino S. J. Biol. Chem. 264:7776-7779(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation." Buse J.B., Yasuda K., Lay T.P., Seo T.S., Olson A.L., Pessin J.E., Karam J.H., Seino S., Bell G.I. Diabetes 41:1436-1445(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-385. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon. |
| [4] | "Identification of the 5' end of the gene encoding a human insulin-responsive glucose transporter." Chiaramonte R., Martini R., Taramelli R., Comi P. Gene 130:307-308(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11. |
| [5] | "A Leu-Leu sequence is essential for COOH-terminal targeting signal of GLUT4 glucose transporter in fibroblasts." Verhey K.J., Birnbaum M.J. J. Biol. Chem. 269:2353-2356(1994) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF 489-LEU-LEU-490. |
| [6] | "The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1." Lalioti V.S., Vergarajauregui S., Pulido D., Sandoval I.V. J. Biol. Chem. 277:19783-19791(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAXX, SUMOYLATION. |
| [7] | "Identification and characterization of p49/STRAP as a novel GLUT4-binding protein." Lisinski I., Matsumoto H., Yver D.R., Schuermann A., Cushman S.W., Al-Hasani H. Biochem. Biophys. Res. Commun. 344:1179-1185(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SRFBP1. |
| [8] | "Role of SGK1 kinase in regulating glucose transport via glucose transporter GLUT4." Jeyaraj S., Boehmer C., Lang F., Palmada M. Biochem. Biophys. Res. Commun. 356:629-635(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-274 BY SGK1. |
| [9] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [10] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [11] | "Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus." Kusari J., Verma U.S., Buse J.B., Henry R.R., Olefsky J.M. J. Clin. Invest. 88:1323-1330(1991) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NIDDM ILE-383. |
| [12] | "Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects." Choi W.H., O'Rahilly S., Buse J.B., Rees A., Morgan R., Flier J.S., Moller D.E. Diabetes 40:1712-1718(1991) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NIDDM ILE-383. |
| [13] | "Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population." O'Rahilly S., Krook A., Morgan R., Rees A., Flier J.S., Moller D.E. Diabetologia 35:486-489(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NIDDM ILE-383. |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia GLUT4 entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M20747 mRNA. Translation: AAA59189.1. M91463 Genomic DNA. Translation: AAA52569.1. BC069615 mRNA. Translation: AAH69615.1. BC069621 mRNA. Translation: AAH69621.1. BC113592 mRNA. Translation: AAI13593.1. BC126164 mRNA. Translation: AAI26165.1. X58489 Genomic DNA. Translation: CAA41399.1. |
| IPI | IPI00027281. |
| PIR | A33801. A49158. |
| RefSeq | NP_001033.1. NM_001042.2. |
| UniGene | Hs.380691. |
3D structure databases | |
| ProteinModelPortal | P14672. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P14672. 1 interaction. |
| MINT | MINT-232088. |
| STRING | 9606.ENSP00000320935. |
PTM databases | |
| PhosphoSite | P14672. |
Polymorphism databases | |
| DMDM | 121761. |
Proteomic databases | |
| PaxDb | P14672. |
| PRIDE | P14672. |
Protocols and materials databases | |
| DNASU | 6517. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000317370; ENSP00000320935; ENSG00000181856. |
| GeneID | 6517. |
| KEGG | hsa:6517. |
| UCSC | uc002gfp.3. human. |
Organism-specific databases | |
| CTD | 6517. |
| GeneCards | GC17P007186. |
| HGNC | HGNC:11009. SLC2A4. |
| HPA | CAB016544. |
| MIM | 125853. phenotype. 138190. gene. |
| neXtProt | NX_P14672. |
| PharmGKB | PA35879. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0477. |
| HOGENOM | HOG000202871. |
| HOVERGEN | HBG014816. |
| InParanoid | P14672. |
| KO | K07191. |
| OMA | KRAMLAN. |
| OrthoDB | EOG4BG8W5. |
| PhylomeDB | P14672. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | arf6_traffickingpathway. Arf6 trafficking events. pi3kciaktpathway. Class I PI3K signaling events mediated by Akt. insulin_glucose_pathway. Insulin-mediated glucose transport. |
| Reactome | REACT_111045. Developmental Biology. REACT_111217. Metabolism. REACT_11123. Membrane Trafficking. REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P14672. |
| Bgee | P14672. |
| CleanEx | HS_SLC2A4. |
| Genevestigator | P14672. |
| GermOnline | ENSG00000181856. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR002441. Glc_transpt_4. IPR020846. MFS_dom. IPR016196. MFS_dom_general_subst_transpt. IPR005828. Sub_transporter. IPR003663. Sugar/inositol_transpt. IPR005829. Sugar_transporter_CS. [Graphical view] |
| Pfam | PF00083. Sugar_tr. 1 hit. [Graphical view] |
| PRINTS | PR01193. GLUCTRSPORT4. PR00171. SUGRTRNSPORT. |
| SUPFAM | SSF103473. MFS_gen_substrate_transporter. 1 hit. |
| TIGRFAMs | TIGR00879. SP. 1 hit. |
| PROSITE | PS50850. MFS. 1 hit. PS00216. SUGAR_TRANSPORT_1. 1 hit. PS00217. SUGAR_TRANSPORT_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL5874. |
| GenomeRNAi | 6517. |
| NextBio | 25341. |
| SOURCE | Search... |
Entry information
| Entry name | GTR4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P14672 Secondary accession number(s): Q14CX2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
